Top

Published in:

Open Access 01-12-2021 | Behavioural Therapy | Research

Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy

Authors: Ely M. Marceau, Gabriella Holmes, Jane Cutts, Lauren Mullaney, Denise Meuldijk, Michelle L. Townsend, Brin F. S. Grenyer

Published in: BMC Psychiatry | Issue 1/2021

Abstract

Background

Reducing substance use in youth is a global health priority. We compared two cohorts from the same 12-week residential substance use disorder (SUD) facility over a 10 year period: Cohort A (2008–2009) and Cohort B (2018–2020). The essential components of the program remained the same with the primary treatment being dialectical behaviour therapy (DBT) plus residential milieu.

Methods

Young people in the current Cohort B (N = 100) versus historical Cohort A (N = 102) had a similar ratio of males (74 vs. 70%) but were slightly older (mean 20.6 vs. 19.5 years). Linear mixed models were used to model outcome measures (global psychiatric symptoms, substance use severity, and quality of life) longitudinally up to 12 months later.

Results

Baseline to end-of-treatment comparisons showed that the current Cohort B had overall higher levels of global psychiatric symptoms (d = 0.70), but both groups reduced psychiatric symptoms (Cohort A: d = 1.05; Cohort B: d = 0.61), and had comparable increases in confidence to resist substance use (d = 0.95). Longitudinal data from the current Cohort B showed significant decreases in substance use severity from baseline to 6-month follow-up (d = 1.83), which were sustained at 12-month follow-up (d = 0.94), and increases in quality of life from baseline to end-of-treatment (d = 0.83).

Conclusions

We demonstrate how DBT plus milieu residential care for young people continues to show positive effects in a 10-year comparison. However, youth seeking treatment today compared to 10 years ago evidenced higher acuity of psychiatric symptoms reinforcing the importance of continuous improvement of psychological treatments.

Trial registration

Australian New Zealand Clinical Trials Registry: trial IDACTRN12618000866202, retrospectively registered on 22/05/2018, .

Available only for authorised users

Johnson SB, Blum RW, Giedd JN. Adolescent maturity and the brain: the promise and pitfalls of neuroscience research in adolescent health policy. J Adolesc Health. 2009;45(3):216–21. https://doi.org/10.1016/j.jadohealth.2009.05.016.CrossRefPubMedPubMedCentral

Bava S, Tapert SF. Adolescent brain development and the risk for alcohol and other drug problems. Neuropsychol Rev. 2010;20(4):398–413. https://doi.org/10.1007/s11065-010-9146-6.CrossRefPubMedPubMedCentral

Gray KM, Squeglia LM. Research review: what have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018;59(6):618–27. https://doi.org/10.1111/jcpp.12783.CrossRefPubMed

Lubman DI, Yücel M, Hall WD. Substance use and the adolescent brain: a toxic combination? J Psychopharmacol. 2007;21(8):792–4. https://doi.org/10.1177/0269881107078309.CrossRefPubMed

Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M. The increasing global health priority of substance use in young people. Lancet Psychiatry. 2016;3(3):251–64. https://doi.org/10.1016/S2215-0366(15)00508-8.CrossRefPubMed

Lubman DI, Yücel M. Drugs, mental health and the adolescent brain: implications for early intervention. Early Interv Psychiatry. 2008;2(2):63–6. https://doi.org/10.1111/j.1751-7893.2008.00059.x.CrossRefPubMed

Australian Institute of Health and Welfare: Alcohol, tobacco and other drugs in Australia. Web report. 2020.

de Andrade D, Elphinston RA, Quinn C, Allan J, Hides L. The effectiveness of residential treatment services for individuals with substance use disorders: a systematic review. Drug Alcohol Depend. 2019;201:227–35. https://doi.org/10.1016/j.drugalcdep.2019.03.031.CrossRefPubMed

Lichvar EK, Stilwell S, Ajmera T, Alexander AL, Plant RW, Panzarella P, et al. Residential treatment of adolescents with substance use disorders: Evidence-based approaches and best practice recommendations. In: Leukefeld C, Gullotta T, editors. Issues in Children's and Families' Lives. Cham: Springer; 2018. p. 191–213.

10.

Fadus MC, Squeglia LM, Valadez EA, Tomko RL, Bryant BE, Gray KM. Adolescent substance use disorder treatment: an update on evidence-based strategies. Curr Psychiatry Rep. 2019;21(10):96. https://doi.org/10.1007/s11920-019-1086-0.CrossRefPubMedPubMedCentral

11.

Hawkins EH. A tale of two systems: co-cccurring mental health and substance abuse disorders treatment for adolescents. Annu Rev Psychol. 2009;60(1):197–227. https://doi.org/10.1146/annurev.psych.60.110707.163456.CrossRefPubMed

12.

Brewer S, Godley MD, Hulvershorn LA. Treating mental health and substance use disorders in adolescents: what is on the menu? Curr Psychiatry Rep. 2017;19(1):5. https://doi.org/10.1007/s11920-017-0755-0.CrossRefPubMed

13.

Linehan MM. Cognitive behavioral treatment of borderline personality disorder. New York: Guilford Press; 1993.

14.

Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319–28. https://doi.org/10.1001/jamapsychiatry.2016.4287.CrossRefPubMed

15.

Marceau EM, Meuldijk D, Townsend ML, Solowij N, Grenyer BFS. Biomarker correlates of psychotherapy outcomes in borderline personality disorder: a systematic review. Neurosci Biobehav Rev. 2018;94:166–78. https://doi.org/10.1016/j.neubiorev.2018.09.001.CrossRefPubMed

16.

Wong J, Bahji A, Khalid-Khan S. Psychotherapies for adolescents with subclinical and borderline personality disorder: a systematic review and meta-analysis. Can J Psychiatry. 2019;65(1):5–15. https://doi.org/10.1177/0706743719878975.CrossRefPubMedPubMedCentral

17.

Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39–47. https://doi.org/10.1151/ascp084239.CrossRefPubMedPubMedCentral

18.

Pennay A, Cameron J, Reichert T, Strickland H, Lee NK, Hall K, et al. A systematic review of interventions for co-occurring substance use disorder and borderline personality disorder. J Subst Abus Treat. 2011;41(4):363–73. https://doi.org/10.1016/j.jsat.2011.05.004.CrossRef

19.

Ritschel LA, Lim NE, Stewart LM. Transdiagnostic applications of DBT for adolescents and adults. Am J Psychother. 2015;69(2):111–28. https://doi.org/10.1176/appi.psychotherapy.2015.69.2.111.CrossRefPubMed

20.

Bergman BG, Greene MC, Slaymaker V, Hoeppner BB, Kelly JF. Young adults with co-occurring disorders: substance use disorder treatment response and outcomes. J Subst Abus Treat. 2014;46(4):420–8. https://doi.org/10.1016/j.jsat.2013.11.005.CrossRef

21.

Morse S, MacMaster S. Characteristics and outcomes of young adult opiate users receiving residential substance abuse treatment. J Evid Inform Soc Work. 2015;12(6):556–66. https://doi.org/10.1080/15433714.2013.872071.CrossRef

22.

Schuman-Olivier Z, Claire Greene M, Bergman BG, Kelly JF. Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder. Drug Alcohol Depend. 2014;144:178–85. https://doi.org/10.1016/j.drugalcdep.2014.09.009.CrossRefPubMedPubMedCentral

23.

Derogatis LR. BSI brief symptom inventory: administration, scoring, and procedural manual. 4th ed. Minneapolis: National Computer Systems; 1993.

24.

Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607–14. https://doi.org/10.1046/j.1360-0443.1995.9056072.x.CrossRefPubMed

25.

Breslin FC, Sobell LC, Sobell MB, Agrawal S. A comparison of a brief and long version of the situational confidence questionnaire. Behav Res Ther. 2000;38(12):1211–20. https://doi.org/10.1016/S0005-7967(99)00152-7.CrossRefPubMed

26.

The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8. https://doi.org/10.1017/S0033291798006667.CrossRef

27.

Duncan BL, Miller SD. The group session rating scale. Author: Jensen Beach; 2007.

28.

McCay E, Carter C, Aiello A, Quesnel S, Howes C, Johansson B. Toward treatment integrity: developing an approach to measure the treatment integrity of a dialectical behavior therapy intervention with homeless youth in the community. Arch Psychiatr Nurs. 2016;30(5):568–74. https://doi.org/10.1016/j.apnu.2016.04.001.CrossRefPubMed

29.

Grech P, Scerri J, Cilia Vincenti S, Sammut A, Galea M, Calleja Bitar D, et al. Service users' perception of the therapeutic milieu in a mental health rehabilitation unit. Issues Ment Health Nurs. 2020;41(11):1019–26. https://doi.org/10.1080/01612840.2020.1757797.CrossRefPubMed

30.

Linehan MM, Schmidt H III, Dimeff LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8(4):279–92.CrossRefPubMed

31.

Rathus JH, Miller AL. Dialectical behavior therapy adapted for suicidal adolescents. Suicide Life Threat Behav. 2002;32(2):146–57. https://doi.org/10.1521/suli.32.2.146.24399.CrossRefPubMed

32.

Moran LR, Kaplan C, Aguirre B, Galen G, Stewart JG, Tarlow N, et al. Treatment effects following residential dialectical behavior therapy for adolescents with borderline personality disorder. Evid Based Pract Child Adolesc Mental Health. 2018;3(2):117–28. https://doi.org/10.1080/23794925.2018.1476075.CrossRef

33.

Fleischhaker C, Böhme R, Sixt B, Brück C, Schneider C, Schulz E. Dialectical behavioral therapy for adolescents (DBT-A): a clinical trial for patients with suicidal and self-injurious behavior and borderline symptoms with a one-year follow-up. Child Adolesc Psychiatry Mental Health. 2011;5(1):3–12. https://doi.org/10.1186/1753-2000-5-3.CrossRef

34.

McMain S, Sayrs JHR, Dimeff LA, Linehan MM. Dialectical behavior therapy for individuals with borderline personality disorder and substance dependence. In: Dimeff LA, Koerner K, editors. Dialectical behavior therapy in clinical practice. New York: Guilford Press; 2007. p. 145–73.

35.

Garland AF, Hawley KM, Brookman-Frazee L, Hurlburt MS. Identifying common elements of evidence-based psychosocial treatments for children's disruptive behavior problems. J Am Acad Child Adolesc Psychiatry. 2008;47(5):505–14. https://doi.org/10.1097/CHI.0b013e31816765c2.CrossRefPubMed

36.

Mitchell PF. Evidence-based practice in real-world services for young people with complex needs: new opportunities suggested by recent implementation science. Child Youth Serv Rev. 2011;33(2):207–16. https://doi.org/10.1016/j.childyouth.2010.10.003.CrossRef

37.

A modified DBT group therapy manual [https://projectairstrategy.org/content/groups/public/@web/@project-air/documents/doc/uow251368.pdf].

38.

Regulator workbook [https://projectairstrategy.org/content/groups/public/@web/@project-air/documents/doc/uow251369.pdf].

39.

Regulator [https://www.dbtregulator.com.au/].

40.

IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. Armonk: IBM Corp; 2017.

41.

Little RJA. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83(404):1198–202. https://doi.org/10.1080/01621459.1988.10478722.CrossRef

42.

Wolfinger R. Covariance structure selection in general mixed models. Commun Stat Simul Comput. 1993;22(4):1079–106. https://doi.org/10.1080/03610919308813143.CrossRef

43.

Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester: Wiley; 2009. https://doi.org/10.1002/9780470743386.

44.

Feingold A. Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods. 2009;14(1):43–53. https://doi.org/10.1037/a0014699.CrossRefPubMedPubMedCentral

45.

DeCou CR, Comtois KA, Landes SJ. Dialectical behavior therapy is effective for the treatment of suicidal behavior: a meta-analysis. Behav Ther. 2019;50(1):60–72. https://doi.org/10.1016/j.beth.2018.03.009.CrossRefPubMed

46.

Caspi A, Moffitt TE. All for one and one for all: mental disorders in one dimension. Am J Psychiatr. 2018;175(9):831–44. https://doi.org/10.1176/appi.ajp.2018.17121383.CrossRefPubMed

47.

Department of Education and Communities. The impact of the raised school leaving age. In: New South Wales Auditor-General's Report; 2012.

48.

Community Mental Health Australia: Taking Our Place; 2012.

49.

Kraemer HC. A source of false findings in published research studies: adjusting for covariates. JAMA Psychiatry. 2015;72(10):961–2. https://doi.org/10.1001/jamapsychiatry.2015.1178.CrossRefPubMed

50.

Kraemer HC. Messages for clinicians: moderators and mediators of treatment outcome in randomized clinical trials. Am J Psychiatr. 2016;173(7):672–9. https://doi.org/10.1176/appi.ajp.2016.15101333.CrossRefPubMed

51.

Hansen WB, Tobler NS, Graham JW. Attrition in substance abuse prevention research: a meta-analysis of 85 longitudinally followed cohorts. Eval Rev. 1990;14(6):677–85. https://doi.org/10.1177/0193841X9001400608.CrossRef

52.

Farabee D, Hawken A, Griffith P. Tracking and incentivizing substance abusers in longitudinal research: results of a survey of National Institute on Drug Abuse-funded investigators. J Addict Med. 2011;5(2):87–91. https://doi.org/10.1097/ADM.0b013e3181e11740.CrossRefPubMedPubMedCentral

53.

Hansten ML, Downey L, Rosengren DB, Donovan DM. Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is "enough" enough? Addiction. 2000;95(9):1403–16. https://doi.org/10.1046/j.1360-0443.2000.959140310.x.CrossRefPubMed

54.

Scott CK. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend. 2004;74(1):21–36. https://doi.org/10.1016/j.drugalcdep.2003.11.007.CrossRefPubMedPubMedCentral

55.

Allott K, Chanen A, Yuen HP. Attrition bias in longitudinal research involving adolescent psychiatric outpatients. J Nerv Ment Dis. 2006;194(12):958–61. https://doi.org/10.1097/01.nmd.0000243761.52104.91.CrossRefPubMed

56.

Farabee D, Schulte M, Gonzales R, Grella CE. Technological aids for improving longitudinal research on substance use disorders. BMC Health Serv Res. 2016;16(1):370. https://doi.org/10.1186/s12913-016-1630-0.CrossRefPubMedPubMedCentral

57.

McMain SF, Chapman AL, Kuo JR, Guimond T, Streiner DL, Dixon-Gordon KL, et al. The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol. BMC Psychiatry. 2018;18(1):230. https://doi.org/10.1186/s12888-018-1802-z.CrossRefPubMedPubMedCentral

58.

Grenyer BFS, Lewis KL, Fanaian M, Kotze B. Treatment of personality disorder using a whole of service stepped care approach: a cluster randomized controlled trial. PLoS One. 2018;13(11):e0206472. https://doi.org/10.1371/journal.pone.0206472.CrossRefPubMedPubMedCentral

59.

Cohen ZD, DeRubeis RJ. Treatment selection in depression. Annu Rev Clin Psychol. 2018;14(1):209–36. https://doi.org/10.1146/annurev-clinpsy-050817-084746.CrossRefPubMed

Title: Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy
Authors: Ely M. Marceau
Gabriella Holmes
Jane Cutts
Lauren Mullaney
Denise Meuldijk
Michelle L. Townsend
Brin F. S. Grenyer
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Behavioural Therapy
Published in: BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-021-03372-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Survival states as indicators of learning performance and biological stress in refugee children: a cross-sectional study with a comparison group

Mental health of undocumented migrants and migrants undergoing regularization in Switzerland: a cross-sectional study

Lasting effects of residential mobility during childhood on psychopathology among Chinese University students

Correction to: Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan

Correction to: Prevalence of depression and associated factors among elderly people in Womberma District, north-west, Ethiopia

A cross-sectional study of mental health and suicidality among trans women in São Paulo, Brazil